Fertility Benefits for Employers

Reply’s program of restorative reproductive medicine (RRM) provides care that is a win-win for employers and employees. Compared to assisted reproductive technology such as IVF, RRM is:

less invasive
less expensive
at least as effective
better for mother and baby's health

Book Employer Consult

For a fraction of the cost of IVF, Reply delivers effective, evidence-based, holistic care, with no joining fee.

“This is about helping couples have a baby naturally and healthily.”

–Dr. Phil Boyle, President

International Institute for Restorative Reproductive Medicine

Competitive, compassionate care

To support employee wellness and maintain a competitive edge in the talent market, it is becoming increasingly essential for employers to offer fertility benefits. In the U.S., 1 in 8 couples faces infertility—an experience that can be devastating and distracting, affecting not only personal well-being but performance and productivity at work.

Reply’s care aims to optimize reproductive and overall health so patients can conceive naturally and have a healthy pregnancy. Our evidence-based program includes RRM medical treatment as well as health coaching to improve lifestyle factors such as nutrition, exercise, sleep, and stress management.

In contrast to IVF that is designed to bypass underlying conditions, RRM is designed to identify and treat underlying conditions. We know couples struggling with infertility typically have 4-6 underlying conditions, and we start our evaluation assessing for 55 different underlying factors. We do not accept “unexplained infertility.”

As underscored in The Economist and elsewhere, there are good reasons for employers to consider alternatives to IVF when mapping employee medical benefits.

A red silhouette of a baby on the cover of the economist

Making babymaking better: A special report on the future of fertility

“The process [of IVF] remains grueling and costly. It is physically painful for women, and emotionally draining for both sexes....All too often, the pain and the cost come to nothing.”

-- The Economist, July 22, 2023

For employers who currently provide fertility benefits:
Including Reply Fertility as a benefit prioritizes health improvements for employees and dependents, while reducing your cost and your risk of poor perinatal outcomes.
For employers considering adding fertility benefits
Starting with Reply Fertility is a rational first step, delivering tremendous value without the short-comings associated with IVF.
Valued by Employees
Two-thirds or more of responding employees are influenced by fertility benefits in their job decision-making—whether seeking a new position, or considering leaving a current position. When you offer fertility benefits you are communicating that you care about employee wellness, work-life balance, and family-building. In turn, employees feel more loyal and committed when their employer offers these benefits.
Evidence-based
Reply Fertility participates in the international research registry, Surveillance of Treatment Outcomes for Restorative Reproductive Medicine (STORRM), and is a member of the International Institute for Restorative Reproductive Medicine, recognized for commitment to exceptional care in restorative reproductive medicine.
RRM Research

“ART [assisted reproductive technology such as IVF] increases the risk of preterm birth, low birth weight, and birth defects. These risks are particularly observed in multiple births; however, a certain risk increase remains also in singletons born after ART….In light of the safety of future ART generations, one rule should apply to all ART: if a method is clinically unnecessary, then avoid it.”

-- Pinborg A., Wennerholm U-B., Bergh C. Long-term outcomes for children conceived by assisted reproductive technology. Fertility and Sterility;

“ART offspring have an increased risk of NCD (noncommunicable diseases), such as malignancies, asthma, obesity, metabolic syndrome, diabetes, cardiovascular diseases, and neurodevelopmental and psychiatric disorders. There are still many controversies in this field and much remains unknown.”

-- Zhang S., Luo Q., Meng R., Yan J., Wu Y., Huang H.; Long-term health risk of offspring born from assisted reproductive technologies; Journal of Assisted Reproduction and Genetics; November 2023.

“There are substantial concerns about expanding use of IVF, including high cost and impact on neonatal outcomes. Epidemiologic studies have demonstrated higher incidence of preterm birth (PTB), low birthweight (LBW), and birth defects among children conceived through IVF….Our findings support efforts to encourage women to give an adequate trial of the least invasive fertility treatment that may work for them.”

-- Sanders, Jessia N, Simonsen Sara E., Porucznik Christina A., Hammoud Ahmad O., Smith Ken R., Stanford, Joseph B; Fertility treatments and the risk of preterm birth among women with subfertility: a linked-data retrospective cohort study; BMC Reproductive Health; March 2022

Delivering value to employer and employees

Competitive, compassionate care

Making babymaking better: A special report on the future of fertility

This benefits everyone.

For employers who currently provide fertility benefits:

For employers considering adding fertility benefits

Valued by Employees

Evidence-based

Contact our business development office

or schedule an employer consult visit

Call us.

“ART offspring have an increased risk of NCD (noncommunicable diseases), such as malignancies, asthma, obesity, metabolic syndrome, diabetes, cardiovascular diseases, and neurodevelopmental and psychiatric disorders. There are still many controversies in this field and much remains unknown.”